Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke.
Nutristroke
The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke: A Randomized Controlled Trial Investigating the Effect of Protein Supplementation on Functional Recovery, Sarcopenia, Osteopenia, and Nutritional Status in Stroke Patients With Hypoalbuminemia.
1 other identifier
interventional
100
1 country
1
Brief Summary
Brief Summary: The main objective of this thesis is to investigate the role of nutrition - specifically the administration of protein supplements (single dose and double dose) - in the rehabilitation of stroke patients with low albumin levels in relation to sarcopenia, osteopenia and functional recovery indices. The study will follow a randomized controlled trial design, incorporating clinical observation, analysis of biochemical markers, and assessment of physical and functional parameters. Participants will be randomly assigned to one of the three groups: (1) Group 1, receiving no protein supplementation (control group), (2) Group 2, receiving a single dose of protein supplement and (3) Group 3, receiving a double dose of protein supplement. The intervention will last for at least six weeks or until the biochemical markers of albumin normalize and the patient resumes regular oral intake. Biochemical assessment with be conducted through regular nutritional evaluations including measurement of serum albumin, prealbumin, C - reactive protein, creatinine, blood glucose and glycosylated hemoglobin (HbA1c), urea, electrolytes, urine albumin and additional inflammatory markers. Bone density will be assessed using DEXA, MBSR and hip measurements to determine the potential improvements resulting from the intervention. Muscle mass will be evaluated using whole - body DEXA analysis, while muscle strength and mobility will be assessed through grip strength tests and fine gait assessments. Functional recovery will be evaluated usings standardized tools for activities of daily living (Barthel Index), mental state (Geriatric Depression Scale) and quality of life (SF - 36), as well as mobility and walking tests such as the Timed Up and Go Test and 6 - Minute Walk Test. The collected data will be analyzed using appropriate statistical tools, including comparison models (ANOVA, Mann - Whitney U test) and correlation models (Pearson - Spearman). This research is expected to enhance theoretical knowledge regarding the relationship between nutrition, biochemical markers and rehabilitation outcomes in stroke patients with hypoalbuminemia. More specifically, it aims to explore the underlying mechanisms through which nutrition affects recovery - a field that remains unexplored. Additionally, the anticipated finding may contribute to the development of clinical guidelines and therapeutic approaches for the nutritional management of patients with low albumin levels, promoting personalized nutritional strategies that support effective post - stroke rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started May 2025
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2025
CompletedStudy Start
First participant enrolled
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 5, 2030
May 8, 2025
April 1, 2025
5 years
April 29, 2025
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum Albumin Levels
Change in serum albumin concentration to assess nutritional status and response to protein supplementation.
Baseline and every 2 weeks for up to 6 weeks
Secondary Outcomes (1)
Muscle Mass (Whole-body DEXA)
Baseline and at week 6
Study Arms (3)
Protein Supplement - Single Dose
EXPERIMENTALParticipants in this arm will receive one dose of protein supplement daily.
Protein Supplement - Double Dose
EXPERIMENTALParticipants in this arm will receive two doses of protein supplement daily.
Control group
NO INTERVENTIONno protein supplementation
Interventions
complete, semi-elemental formula for tube feeding and orla intake based on peptides, in powder form, low in fat (32% of energy), high in MCTs (\>90% of total fat) free of fiber and gluten
Eligibility Criteria
You may qualify if:
- Age range: Adults aged 18 to 85 years
- Diagnosis: Patients diagnosed with a stroke (cerebrovascular accident) within the last 4 to 6 weeks
- Serum albumin levels: Patients with low serum albumin levels (\< 3.5 g / dL)
- Nutritional intervention requirement: Patients who require nutritional intervention to support rehabilitation and nutrition
- Informed consent: Patients who have completed the consent form for participation in the study and acceptance of the intervention
You may not qualify if:
- Severe infections or serious cardiopulmonary conditions: Patients with severe infections or serious cardiopulmonary conditions requiring immediate medical intervention, which may affect nutrition and rehabilitation
- Comorbidities: Patients with comorbid conditions such as renal or liver disease
- History of stroke or neurological conditions: Patients with a history of stroke or other neurological conditions who do not meet the criteria for rehabilitation
- Severe mental or psychological conditions: Patients with severe mental or psychological conditions who are unable to understand or consent to participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Ioannina
Ioannina, Greece, 4500, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Avraam Ploumis
University Hospital, Ioannina
Central Study Contacts
Avraam Ploumis
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single (Outcomes Assessor
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistan Professor of PMR,Orthopaedic Spine Surgeon
Study Record Dates
First Submitted
April 29, 2025
First Posted
May 8, 2025
Study Start
May 5, 2025
Primary Completion (Estimated)
May 5, 2030
Study Completion (Estimated)
May 5, 2030
Last Updated
May 8, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share